Sastasundar Ventures Ltd
Sastasundar Ventures Limited is a Core Investment Company (CIC) focusing on the business of digital network of healthcare and portfolio management services. The Company aims to provide healthcare services at a reasonable cost with its innovative information and knowledge based web portal.[1]
- Market Cap ₹ 932 Cr.
- Current Price ₹ 293
- High / Low ₹ 500 / 276
- Stock P/E
- Book Value ₹ 85.7
- Dividend Yield 0.00 %
- ROCE -0.31 %
- ROE -0.33 %
- Face Value ₹ 10.0
Pros
- Company is almost debt free.
Cons
- Stock is trading at 3.42 times its book value
- Company has low interest coverage ratio.
- Company has a low return on equity of -0.23% over last 3 years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Finance Industry: Finance & Investments
Part of BSE Allcap BSE Healthcare BSE SmallCap
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
17.83 | 2.67 | 2.29 | 2.10 | 0.98 | 1.43 | 2.47 | 0.31 | 0.28 | 0.19 | 0.25 | 0.45 | 0.19 | |
4.53 | 2.14 | 2.00 | 2.00 | 1.77 | 1.90 | 1.88 | 1.33 | 0.90 | 1.04 | 1.41 | 1.93 | 1.95 | |
Operating Profit | 13.30 | 0.53 | 0.29 | 0.10 | -0.79 | -0.47 | 0.59 | -1.02 | -0.62 | -0.85 | -1.16 | -1.48 | -1.76 |
OPM % | 74.59% | 19.85% | 12.66% | 4.76% | -80.61% | -32.87% | 23.89% | -329.03% | -221.43% | -447.37% | -464.00% | -328.89% | -926.32% |
0.07 | 0.09 | 0.16 | -2.26 | -1.34 | 14.00 | 0.22 | 1.87 | 0.68 | 0.72 | 2.00 | 0.73 | 1.02 | |
Interest | 0.07 | 0.02 | 0.02 | 0.02 | 0.03 | 0.02 | 0.02 | 0.03 | 0.03 | 0.03 | 0.03 | 0.04 | 0.01 |
Depreciation | 0.39 | 0.36 | 0.41 | 0.34 | 0.27 | 0.23 | 0.21 | 0.18 | 0.17 | 0.18 | 0.16 | 0.10 | 0.10 |
Profit before tax | 12.91 | 0.24 | 0.02 | -2.52 | -2.43 | 13.28 | 0.58 | 0.64 | -0.14 | -0.34 | 0.65 | -0.89 | -0.85 |
Tax % | 24.48% | -141.67% | -5,200.00% | -17.86% | 0.00% | 14.83% | 39.66% | 0.00% | 0.00% | 14.71% | 0.00% | 0.00% | |
9.76 | 0.59 | 1.05 | -2.07 | -2.44 | 11.32 | 0.36 | 0.64 | -0.14 | -0.39 | 0.65 | -0.89 | -0.85 | |
EPS in Rs | 3.07 | 0.19 | 0.33 | -0.65 | -0.77 | 3.56 | 0.11 | 0.20 | -0.04 | -0.12 | 0.20 | -0.28 | -0.27 |
Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Compounded Sales Growth | |
---|---|
10 Years: | -16% |
5 Years: | -29% |
3 Years: | 17% |
TTM: | 80% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
TTM: | -393% |
Stock Price CAGR | |
---|---|
10 Years: | 14% |
5 Years: | 29% |
3 Years: | -17% |
1 Year: | -37% |
Return on Equity | |
---|---|
10 Years: | 0% |
5 Years: | 0% |
3 Years: | 0% |
Last Year: | 0% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 31.81 | 31.81 | 31.81 | 31.81 | 31.81 | 31.81 | 31.81 | 31.81 | 31.81 | 31.81 | 31.81 | 31.81 |
Reserves | 192.73 | 193.32 | 194.15 | 192.08 | 189.64 | 240.01 | 240.96 | 241.59 | 241.44 | 241.00 | 241.61 | 240.72 |
0.05 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
14.62 | 1.81 | 0.64 | 0.36 | 1.81 | 0.79 | 6.03 | 0.56 | 0.27 | 0.30 | 0.43 | 0.40 | |
Total Liabilities | 239.21 | 226.94 | 226.60 | 224.25 | 223.26 | 272.61 | 278.80 | 273.96 | 273.52 | 273.11 | 273.85 | 272.93 |
4.65 | 4.40 | 3.83 | 4.47 | 4.19 | 4.17 | 3.95 | 3.40 | 3.24 | 3.12 | 2.13 | 2.02 | |
CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 229.47 | 215.59 | 219.66 | 217.29 | 217.69 | 259.11 | 274.15 | 269.56 | 269.43 | 264.98 | 265.60 | 264.87 |
5.09 | 6.95 | 3.11 | 2.49 | 1.38 | 9.33 | 0.70 | 1.00 | 0.85 | 5.01 | 6.12 | 6.04 | |
Total Assets | 239.21 | 226.94 | 226.60 | 224.25 | 223.26 | 272.61 | 278.80 | 273.96 | 273.52 | 273.11 | 273.85 | 272.93 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
1.90 | 3.57 | -4.06 | -0.01 | 1.27 | -9.20 | 3.61 | -0.83 | -0.51 | -0.52 | -0.63 | -1.21 | |
-0.13 | -3.72 | 3.94 | 0.23 | -1.00 | 12.34 | -7.62 | 0.97 | 0.47 | 0.54 | 0.64 | 1.09 | |
-3.69 | -0.05 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Net Cash Flow | -1.92 | -0.20 | -0.12 | 0.22 | 0.28 | 3.14 | -4.01 | 0.14 | -0.04 | 0.02 | 0.02 | -0.11 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 0.82 | 0.00 | 6.38 | 0.00 | 14.90 | 206.75 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Inventory Days | ||||||||||||
Days Payable | ||||||||||||
Cash Conversion Cycle | 0.82 | 0.00 | 6.38 | 0.00 | 14.90 | 206.75 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Working Capital Days | -22.93 | -185.92 | -65.35 | -38.24 | -610.82 | 1,079.69 | -799.45 | 259.03 | 521.43 | 8,663.95 | 7,986.20 | 4,485.44 |
ROCE % | 5.91% | 0.12% | 0.02% | -0.06% | -0.48% | -0.25% | 0.15% | -0.23% | -0.04% | -0.12% | -0.21% | -0.31% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
2d - Submission of audio recording for Q2 FY25 earnings call.
- Announcement under Regulation 30 (LODR)-Investor Presentation 16 Nov
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
15 Nov - Publication of Unaudited Financial Results for the quarter and half year ended 30th September, 2024 in the Newspapers
- Results - Unaudited Financial Results For The Quarter And Half Year Ended 30Th September, 2024 14 Nov
-
Board Meeting Outcome for Outcome Of Board Meeting Held Today, The 14Th November, 2024
14 Nov - Board approved unaudited financial results for Q2 FY2024.
Annual reports
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from nse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
Concalls
-
Nov 2024TranscriptNotesPPT
-
Oct 2024TranscriptNotesPPT
-
Jun 2024TranscriptNotesPPT
-
Feb 2024Transcript PPT
-
Nov 2023Transcript PPT
-
Aug 2023Transcript PPT
-
Jul 2023TranscriptNotesPPT
-
Mar 2023TranscriptNotesPPT
-
Feb 2023TranscriptNotesPPT
-
Nov 2022TranscriptNotesPPT
-
Sep 2022TranscriptNotesPPT
-
Jun 2022TranscriptNotesPPT
-
Mar 2022TranscriptNotesPPT
-
Dec 2021TranscriptNotesPPT
-
Nov 2021TranscriptNotesPPT
-
Nov 2021TranscriptNotesPPT
-
Aug 2021TranscriptNotesPPT
-
Jun 2021TranscriptNotesPPT
-
Feb 2021TranscriptNotesPPT
-
Nov 2020TranscriptNotesPPT
-
Aug 2018TranscriptNotesPPT
-
Feb 2018TranscriptNotesPPT
-
Nov 2017TranscriptNotesPPT
Leadership
Sastasundar group is #1 pharma distributor in West Bengal.[1]